Log In
Print
BCIQ
Print
Print this Print this
 

Nav 1.7 blocker (PF-05089771, PF-5089771)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionSmall molecule inhibitor of Nav 1.7 sodium channel
Molecular Target Nav1.7 (SCN9A)
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat chronic pain; Treat pain and related disorders; Treat pain associated with erythromelalgia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today